Wine Compound Resveratrol Linked to Slowing Alzheimer’s Disease Symptoms

Polyphenol found in grape skins slowed decline of a protein linked to the disease
Nov 3, 2015

A study from Georgetown University has found that people suffering from mild to moderate Alzheimer’s disease who took large doses of resveratrol, the polyphenolic compound found in red wine and other foods, maintained higher levels of a protein called amyloid-beta 40. The scientists are excited by the findings because amyloid-beta 40 is a key biomarker for doctors monitoring Alzheimer’s patients. It declines as Alzheimer’s advances, thus the study suggests that resveratrol may help slow the disease’s progression.

Dr. Scott Turner, director of Georgetown’s memory disorders program, and his team published the study in September in the journal Neurology. For their research, they monitored 119 people, all suffering from some form of mild to moderate Alzheimer’s and ranging in age from 50 to 70 years old. Some subjects took concentrated capsules of resveratrol, while others took a placebo.

After one year, those taking resveratrol displayed a smaller decline in amyloid-beta 40. After one year, the resveratrol group’s baseline amyloid-beta 40 levels fell by less than 1 percent, while the placebo group’s levels fell by more than 14.3 percent.

The study did require a hefty dose of resveratrol, however. In wine terms it would require raiding your cellar and drinking about 1,000 bottles of wine per day. Patients took a concentrated pill form, up to 2,000 mg a day toward the end of the trial, and showed no adverse effects compared to those who took the placebo.

What this study effectively shows is that resveratrol can stabilize this biomarker, and therefore could stabilize Alzheimer’s symptoms. Dr. Turner noted in the study that it’s not clear whether resveratrol can have a direct, long-term impact on the disease, but its effect on amyloid-beta 40 certainly holds promise for future research. The next phase of the study will expand it to a larger group and address the cognitive effects of taking such a dose of resveratrol.

Health Alzheimer's / Dementia Resveratrol News

You Might Also Like

2 Restaurants Win New Grand Awards in 2022

2 Restaurants Win New Grand Awards in 2022

Wine Spectator recognizes dining destinations in New York and Napa Valley with its top …

Jun 23, 2022
Exclusive: Foley Family Wines Buys Napa’s Silverado Vineyards

Exclusive: Foley Family Wines Buys Napa’s Silverado Vineyards

Vintner, finance executive and hockey team owner Bill Foley secures 300 acres of Napa vines …

Jun 21, 2022
Josh Jensen, Founder of Calera Wine Company, Dies at 78

Josh Jensen, Founder of Calera Wine Company, Dies at 78

The California pioneer turned his passion for Pinot Noir into one of the state's most …

Jun 13, 2022
Instagram Live Chats: View Wine Spectator's Upcoming Schedule

Instagram Live Chats: View Wine Spectator's Upcoming Schedule

Our next episode features J Vineyards winemaker Nicole Hitchcock

Jun 24, 2022
Napa Valley Barrel Auction Raises $1.5 Million in Collective Napa Valley Debut

Napa Valley Barrel Auction Raises $1.5 Million in Collective Napa Valley Debut

The Napa Valley Vintners association has replaced the landmark Auction Napa Valley charity …

Jun 8, 2022
Vegas Vibes: Highlights from Wine Spectator’s 2022 Grand Tour Kick-Off

Vegas Vibes: Highlights from Wine Spectator’s 2022 Grand Tour Kick-Off

The annual supertasting tour rolls out with 224 wineries and more than 1,000 attendees at …

Jun 7, 2022